Synucleinopathies
·MeSH: Synucleinopathies
2 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| ub-312 | Vaxxinity, Inc. (VAXX) |
Preclinical(1)
| Drug | Company |
|---|---|
| pr004 | Prevail Therapeutics Inc. (PRVL) |
Compare drugs
Frequently asked questions
How many drugs are in development for Synucleinopathies?
BioSniper tracks 2 drugs in development for Synucleinopathies across 2 companies.
How many clinical trials target Synucleinopathies?
There are 1 clinical trial targeting Synucleinopathies tracked by BioSniper.
Deep-dive into Synucleinopathies
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis